CT引导下经皮肺活检的常规影像-病理一致性评估可增加发现的癌症数量
本研究对2016年7月1日至2021年9月30日连续828例CT引导下肺活检进行常规影像-病理一致性评估,将224例非恶性结果分为一致(62%)、不一致(24%)和不确定(14%),随访证实三组恶性率分别为2%、61%和20%(p<0.001),重复活检较影像随访更快达到确诊(33天 vs 114天,p=0.01)。
要点
- 非恶性肺活检结果中,影像-病理不一致者恶性率61%,不确定者20%,一致者仅2%。
- 常规一致性评估可识别非恶性活检结果中漏诊恶性肿瘤的高风险患者。
- 重复活检确诊中位时间33天,显著短于影像随访的114天(p=0.01)。
核心结论
- CT引导下肺活检的常规影像-病理一致性评估能正确识别非恶性结果中漏诊恶性肿瘤的高风险患者,重复活检是达到确诊最快的方法。
研究设计与样本
- 连续纳入2016年7月1日至2021年9月30日接受CT引导下肺活检的患者,由操作放射科医生在常规会议上评估病理与影像的一致性;以重复活检、手术标本或随访的病理为参考标准;共828例活检来自795例患者(中位年龄70岁,IQR 61-77),423/828(51%)为女性。
诊断标准与关键数值
- 一致性定义为病理与影像表现相符;不一致为病理无法解释影像表现;不确定为病理可解释影像表现但存在恶性疑虑;非恶性结果中一致138/224(62%)、不一致54/224(24%)、不确定32/224(14%)。
临床应用与阅片要点
- 对CT引导下肺活检非恶性结果,按影像-病理一致性分类:不一致者恶性率61%、不确定者20%、一致者2%,三组恶性率差异显著(p<0.001);对不一致和不确定结果原文提供了建议,重复活检确诊中位33天(IQR 18-133)快于影像随访的114天(IQR 69-206)(p=0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Routine concordance evaluation between pathology and imaging findings was introduced for CT-guided biopsies.
PURPOSE: To analyze malignancy rate in concordant, discordant, and indeterminate non-malignant results of CT-guided lung biopsies.
METHODS: Concordance between pathology results and imaging findings of consecutive patients undergoing CT-guided lung biopsy between 7/1/2016 and 9/30/2021 was assessed during routine meetings by procedural radiologists. Concordant was defined as pathology consistent with imaging findings; discordant was used when pathology could not explain imaging findings; indeterminate when pathology could explain imaging findings but there was concern for malignancy. Recommendations for discordant and indeterminate were provided. All the malignant results were concordant. Pathology of repeated biopsy, surgical sample, or follow-up was considered reference standard.
RESULTS: Consecutive 828 CT-guided lung biopsies were performed on 795 patients (median age 70 years, IQR 61-77), 423/828 (51%) women. On pathology, 224/828 (27%) were non-malignant. Among the non-malignant, radiology-pathology concordance determined 138/224 (62%) to be concordant with imaging findings, 54/224 (24%) discordant, and 32/224 (14%) indeterminate. When compared to the reference standard, 33/54 (61%) discordant results, 6/30 (20%) indeterminate, and 3/133 (2%) concordant were malignant. The prevalence of malignancy in the three groups was significantly different (p < 0.001). Time to diagnosis was significantly different between patients who reached the diagnosis with imaging follow-up (median 114 days, IQR 69-206) compared to repeat biopsy (33 days, IQR 18-133) (p = 0.01).
CONCLUSION: Routine radiology-pathology concordance evaluation of CT-guided lung biopsy correctly identifies patients at high risk for missed diagnosis of malignancy. Repeat biopsy is the fastest method to reach diagnosis.
CLINICAL RELEVANCE STATEMENT: A routine radiology-pathology concordance assessment identifies patients with non-malignant CT-guided lung biopsy result who are at greater risk of missed diagnosis of malignancy.
KEY POINTS: • A routine radiology-pathology concordance evaluation of CT-guided lung biopsies classified 224 non-malignant results as concordant, discordant, or indeterminate. • The percentage of malignancy on follow-up was significantly different in concordant (2%), discordant (61%), and indeterminate (20%) (p < 0.001). • Time to definitive diagnosis was significantly shorter with repeat biopsy (33 days), compared to imaging follow-up (114 days), p = 0.01.
引用
- Rigiroli F, Hamam O, Kavandi H, et al. Routine radiology-pathology concordance evaluation of CT-guided percutaneous lung biopsies increases the number of cancers identified. Eur Radiol. 2023. PMID: 37857902. doi:10.1007/s00330-023-10353-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。